
60 Degrees Pharmaceuticals Investor Relations Material
Latest events

Q1 2025
15 May, 2025

Q4 2024
27 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from 60 Degrees Pharmaceuticals Inc
Access all reports
60 Degrees Pharmaceuticals Inc. is a pharmaceutical company focused on developing and commercializing treatments for infectious diseases, particularly those affecting travelers and people in tropical and subtropical regions. The company’s primary focus is on therapeutics for diseases such as malaria and dengue fever, aiming to address unmet needs in global health. 60 Degrees Pharmaceuticals collaborates with various research organizations and government agencies to advance its product pipeline and expand access to its treatments in underserved regions. The company is headquartered in Washington, D.C., and its shares are listed on the NASDAQ.
Key slides for 60 Degrees Pharmaceuticals Inc


Q4 2024
60 Degrees Pharmaceuticals Inc


Q4 2024
60 Degrees Pharmaceuticals Inc
Latest articles
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
Ticker symbol
SCTP
Country
🇺🇸 United States